Navidea Biopharma (NAVB) Reports Q1 Loss of $0.24
Tweet
Share
E-mailGet Alerts NAVB Hot Sheet
Join SI Premium – FREE
Navidea Biopharma (NYSE: NAVB) reported Q1 EPS of ($0.24), versus ($0.83) reported last year. Revenue for the quarter came in at $136 thousand, versus $275.65 thousand reported last year.
For earnings history and earnings-related data on Navidea Biopharma (NAVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
- Logistic Properties of the Americas (LPA) Reports Q2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
